Citation Impact
Citing Papers
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Influence of heart rate on mortality among persons with hypertension: The Framingham Study
1993
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial Infarction
1988
Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation
2008
Effect of Smoking Cessation on Mortality After Myocardial Infarction
2000
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure
2001
Mortality and Morbidity During a Five‐year Follow‐up of Diabetics with Myocardial Infarction
1988
Digitoxin medication and cancer; case control and internal dose-response studies
2001
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study
1997
Is atrial fibrillation an inflammatory disorder?
2005
Inflammation in the genesis and perpetuation of atrial fibrillation
2005
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?
2004
Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery Disease
1988
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies
2007
Successes and failures of current treatment of heart failure
1998
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Diabetes and Atherosclerosis
2002 Standout
Gout
2016 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
1992 Standout
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
Long-Term Complications of Diabetes Mellitus
1993 Standout
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?
2005
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention
2011
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients
1999
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
Uncomplicated Urinary Tract Infection
2012 Standout
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
2005
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
2004
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine
2004
Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice
2003
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Myocarditis
2009 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Evaluating the federal role in financing health-related research
1996 StandoutNobel
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Serum glucose levels during long-term observation of treated and untreated men with mild hypertension
1984
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
Blood pressure, stroke, and coronary heart disease
1990 Standout
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
1986
The Diagnostic Accuracy of Rapid Dipstick Tests to Predict Urinary Tract Infection
1991
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
Blood Pressure Lowering in Type 2 Diabetes
2015
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population
2007
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
1982
Heart rate as a therapeutic target in heart failure?
2003
Works of T Gundersen being referenced
Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion
2004
Absence of effect on exercise capacity of 12-weeks treatment with ramipril in patients with moderate congestive heart failure
1994
Treatment of acute gonococcal urethritis in men with simultaneous infection with Chlamydia trachomatis.
1984
Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest
1986
[Chronic heart failure--suggestion to a management program].
1999
[Allopurinol hypersensitivity syndrome].
1989
Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction.
1985
Timolol Treatment After Myocardial Infarction in Diabetic Patients
1983
Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failure
1984
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Prepared for the Norwegian Multicentre Study Group.
1982
Timolol maleate and HDL cholesterol after myocardial infarction
1985
Acute and long‐term response to enalapril in congestive failure.
1984